Agenda and minutes
PDF 464 KBVenue: Committee Room 1 - Senedd
Contact: Policy: Llinos Dafydd / Legislation: Fay Buckle
| Expected timing | No. | Item |
|---|---|---|
|
Introductions, apologies and substitutions Minutes: 1.1 Apologies were received from Vaughan Gething and Darren
Millar. There were no substitutions. |
||
(09.30 - 12.10) |
Inquiry into the implementation of the NSF for diabetes in Wales and its future direction - Oral evidence |
|
|
09.30 - 10.20: Diabetes UK Cymru HSC(4)-30-12 paper 1 – Evidence from Diabetes UK Cymru Dai Williams, Director, Diabetes UK Cymru Jason Harding, Policy Manager, Diabetes UK Cymru Supporting documents: Minutes: 2.1 The witnesses responded to questions from members of the Committee. |
||
|
10.20 - 11.10: Royal College of Physicians, Association of British Clinical Diabetologists, and British Medical Association HSC(4)-30-12 paper 2 – Evidence from the Royal College of Physicians and the Association of British Clinical Diabetologists Dr Meurig Williams, Royal College of Physicians Regional Adviser for Wales Dr Aled Roberts, Association of British Clinical Diabetologists HSC(4)-30-12 paper 3 – Evidence from the British Medical Association Dr Ian Millington Dr Mark Temple Supporting documents:
Minutes: 2.2 The witnesses responded to questions from members of the
Committee. 2.3 Dr Temple agreed to provide a note for the Committee on the reduction in the number of public health doctors in Wales over recent years. |
||
|
11.20 - 12.10: Royal Pharmaceutical Society and Community Pharmacy Wales HSC(4)-30-12 paper 4 – Evidence from the Royal Pharmaceutical Society Mair Davies, Chair, Welsh Pharmacy Board Paul Gimson, Director for Wales, Royal Pharmaceutical Society HSC(4)-30-12 paper 5 – Evidence from Alliance Boots Russell Goodway, Chief Executive, Community Pharmacy Wales Marc Donovan, Community Pharmacy Wales Board Member and Head of Professional Capability, Alliance Boots
Supporting documents: Minutes: 2.4 The witnesses responded to questions from members of the
Committee. 2.5 Mr Gimson agreed to share with the Committee a paper on
the results of pharmacists providing structured education for diabetes
patients. |
||
(12.10 - 12.15) |
Papers to note Minutes of the meetings held on 17 & 25 October, and 7 November Supporting documents: |
|
|
Forward Work Programme - November to December 2012 HSC(4)-30-12 paper 6 Supporting documents: Minutes: 3.1 The Committee noted the paper. 3.2 The Committee agreed to seek time early in 2013 to meet with the National Clinical Forum, the Wales Deanery and other national organisations to continue its consideration of health board service reconfiguration plans. |
||
|
Correspondence from Mick Antoniw AM on the Recovery of Medical Costs for Asbestos Diseases (Wales) Bill HSC(4)-30-12 paper 7 Supporting documents: Minutes: 3.3 The Committee noted the letter. 3.4 Mick Antoniw informed the Committee that, as the Member in Charge of the Bill, he would not attend the Committee sessions at which the Bill would be considered. |
||
|
Correspondence from the Leader of the House on the Smoke Free Premises (Amendment) (Wales) Regulations HSC(4)-30-12 paper 8 Supporting documents: Minutes: 3.5 The Committee noted the letter. |
||
(12.15) |
Motion under Standing Order 17.42(vi) to exclude the public from this meeting for item 5 and for the meeting on 21 November for item 1 Minutes: 4.1 The Committee agreed the Motion. |
|
(13.15 - 14.30) |
Inquiry into Residential Care for Older People - Consideration of draft report Minutes: 5.1 The Committee considered the draft report and agreed to schedule a session to consider it again on 21 November. |
|
|
Transcript View the meeting transcript. |